Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003527225 | SCV004296471 | pathogenic | Congenital myasthenic syndrome 4A | 2023-01-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant is also known as 509insA. This premature translational stop signal has been observed in individual(s) with CHRNE-related conditions (PMID: 12417530). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn190Lysfs*12) in the CHRNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHRNE are known to be pathogenic (PMID: 22678886). |